| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/06/2008 | EP1951674A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 08/06/2008 | EP1660491B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/06/2008 | EP1651621B1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 08/06/2008 | EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 08/06/2008 | CN101238120A Urea derivatives methods for their manufacture and uses thereof |
| 08/06/2008 | CN101238118A Salts and polymorphs of a VEGF-R inhibitor |
| 08/06/2008 | CN101238106A Fluoro substituted 2-oxo azepan derivatives |
| 08/06/2008 | CN101235131A Method for preparing benzoxazine intermediate containing propargyl ether and resin thereof |
| 08/06/2008 | CN101235033A Benzoxazine containing maleimide and allyl ether, and preparation method thereof |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408570C EP4 receptor antagonists |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/05/2008 | US7408067 Neuregulins such as 4-(4-Hydroxyphenylthio)-piperidine trifluoroacetate for treatment of dysfunctions of central and autonomic nervous systems |
| 08/05/2008 | US7408065 P2X7 receptor antagonists and their use |
| 08/05/2008 | US7408063 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407969 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 08/05/2008 | US7407968 Compounds |
| 08/05/2008 | US7407961 Adenosine antagonists; depression, dementia (e.g. Alzheimer's disease), Parkinson's disease, anxiety, pain, cerebrovascular disorders, heart failure, hypertension, edema, obesity, bronchial asthma |
| 08/05/2008 | US7407960 e.g. 2-{4-[(2R)-2-hydroxy-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-((1S)-1-phenylethyl)acetamide; fatty acid oxidation inhibitor; cardiovascular diseases: atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's angina, stable and unstable angina, and diabetes |
| 08/05/2008 | US7407950 N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands |
| 08/05/2008 | CA2417081C New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 08/05/2008 | CA2314514C Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents |
| 08/05/2008 | CA2293358C Tricyclic sulfonamide inhibitors of farnesyl-protein transferase |
| 08/05/2008 | CA2279319C Benzofurazan compounds which enhance ampa receptor activity |
| 08/05/2008 | CA2176649C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 07/31/2008 | WO2008091752A2 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents |
| 07/31/2008 | WO2008091580A2 Fungicidal amides |
| 07/31/2008 | WO2008091021A1 Heterocyclidene-n-(aryl)acetamide derivative |
| 07/31/2008 | WO2008090570A1 Novel antimicrobials |
| 07/31/2008 | WO2008090382A1 Thiazole and oxazole derivatives for use in the treatment of prion diseases, cancer and conditions of the central nervous system as well as in the regulation of stem cells |
| 07/31/2008 | WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor |
| 07/31/2008 | WO2008090046A1 Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone |
| 07/31/2008 | WO2008089933A2 Benzoquinazole derivatives |
| 07/31/2008 | WO2008073687A3 Compounds and compositions as protein kinase inhibitors |
| 07/31/2008 | WO2008061236A3 Sulfoximines as kinase inhibitors |
| 07/31/2008 | WO2008011557A3 Heteroaryl inhibitors of rho kinase |
| 07/31/2008 | WO2007077201A9 Piperazine compounds with a herbicidal action |
| 07/31/2008 | US20080182879 e.g. 6-hydroxy-2-[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]chromone; tyrosine kinase inhibitors, anticarcinogenic and antiinflammatory agent; cerebral, genito-urinary tract, lymphatic system, stomach, laryngeal, pancreatic, breast or lung tumor; rheumatoid arthritis, psoriasis, contact dermatitis |
| 07/31/2008 | US20080182874 e.g. 1-[6-Chloro-5-[(tricyclo[3.3.1.13,7]dec-1-ylacetyl)amino]-2-quinolinyl]-4piperidinecarboxylic acid; adamantyl-containing purinergic receptor P2X7 antagonists; antiinflammatory agent, immune or cardiovascular diseases; asthma, chronic obstructive pulmonary disease, rheumatoid arthritis |
| 07/31/2008 | US20080182860 Pyrimidine Compounds as Purine Receptor Antagonist |
| 07/31/2008 | US20080182854 4-Amino-5-Cyanopyrimidine Derivatives |
| 07/31/2008 | US20080182850 3-(heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4 |
| 07/31/2008 | US20080182845 Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| 07/31/2008 | US20080182843 Mitotic Kinesin Inhibitors |
| 07/31/2008 | US20080182840 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 07/31/2008 | US20080182302 Open reading frames which encode polypeptides sufficient to direct the biosynthesis synthesis of a safracin molecule having improved properties and that could be used in the hemi-synthesis of new ecteinascidins compounds; combinatorial chemistry; antitumor agents; broad-spectrum antibiotics; bactericides |
| 07/31/2008 | CA2676020A1 Heterocyclidene-n-(aryl) acetamide derivative |
| 07/31/2008 | CA2674921A1 Benzoquinazoline derivatives |
| 07/30/2008 | EP1950206A1 Benzoxazocines and their use as monoamine-reuptake inhibitors |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1948649A2 Fungicidal carboxamides |
| 07/30/2008 | EP1948648A2 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives |
| 07/30/2008 | EP1948645A1 Tricyclo substituted amides |
| 07/30/2008 | EP1948644A1 Tricyclo substituted amides |
| 07/30/2008 | EP1948639A2 Novel carbocyclic fused cyclic amines |
| 07/30/2008 | EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 07/30/2008 | EP1948624A2 Process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives |
| 07/30/2008 | EP1948616A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 07/30/2008 | EP1948605A2 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 07/30/2008 | EP1948193A2 Aminopyrimidines useful as kinase inhibitors |
| 07/30/2008 | EP1737462B1 Pyrimidines with tie2 (tek) activity |
| 07/30/2008 | EP1660447B1 Cyclic amine bace-1 inhibitors having a heterocyclic substituent |
| 07/30/2008 | EP1633729B1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | CN101233130A Diazine azole derivatives, their manufacture and use as pharmaceutical agents |
| 07/30/2008 | CN101233129A Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases |
| 07/30/2008 | CN101233128A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 07/30/2008 | CN101233119A Novel heterocyclic nf-kb inhibitors |
| 07/30/2008 | CN101230060A Substitutional piperidines |
| 07/30/2008 | CN101230038A Pyridine carboxamide derivatives and their use as pesticides |
| 07/30/2008 | CN101230008A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406453C 4-anilino-quinazoline derivatives as antiproliferative agents |
| 07/30/2008 | CN100406446C Benzoxazole derivatives and their use as adenosine receptor ligands |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | US7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/29/2008 | US7405231 Oxidized thioether derivatives |
| 07/29/2008 | US7405228 Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405216 Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) |
| 07/29/2008 | US7405215 e.g. [3-(3-benzyl-4-oxo-3,4-dihydro-phthalazin-1-yl)-indol-1-yl]-acetic acid; inhibit binding of endogenous ligands, including prostaglandin PGD2 and its metabolites and certain thromboxane metabolites (such as 11-dehydro-TXB2), to CRTH2; antiallergent; asthma, bronchitis, rhinitis, cough, psoriasis |
| 07/29/2008 | US7405211 Therapeutic morpholino-substituted compounds |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2262997C Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 07/29/2008 | CA2256022C 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/24/2008 | WO2008089005A2 Renin inhibitors |
| 07/24/2008 | WO2008087936A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes |
| 07/24/2008 | WO2008087529A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | WO2008087383A1 Purification process comprising dissolving an organic compound in carbonated water and freeze-drying |
| 07/24/2008 | WO2008087178A1 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |